Structure via PubChem · Public domain (PubChem)
rupatadine
Sign in to savethumb|Rupafin (Rupatadine) tablets
Chemical data
- Formula
- C26H26ClN3
- Molecular weight
- 416 g/mol
- IUPAC name
- 13-chloro-2-[1-[(5-methyl-3-pyridinyl)methyl]piperidin-4-ylidene]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene
- SMILES
- CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2
- InChIKey
- WUZYKBABMWJHDL-UHFFFAOYSA-N
- XLogP
- 5.8
- Polar surface area
- 29 Ų
- H-bond donors
- 0
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- Admin. routes
- oral
- Indications
- urticaria, rheumatoid arthritis, Mastocytosis, allergic disease
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 415.182
- Has use
- medication
Show 4 more facts
- canonical SMILES
- CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2
- chemical formula
- C₂₆H₂₆ClN₃
- defined daily dose
- 10
- Commons category
- Rupatadine
Sources (3)
via Wikidata · CC0
~2 min read
Encyclopedic overview
8 sectionsContents
- Medical uses
- Side effects
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- History
- Brand names
- References
thumb|Rupafin (Rupatadine) tablets
Rupatadine is a second generation antihistamine and platelet-activating factor antagonist used to treat allergies. It was discovered and developed by and is marketed as Rupafin and under several other trade names.
Excerpted from Wikipedia’s “rupatadine” article, available under the CC BY-SA 4.0 licence.